DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Takaguchi K, Toyoda H, Tsutsui A. , et al.
Real-world virological efficacy and safety of daclatasvir/asunaprevir/beclabuvir in patients with chronic hepatitis C virus genotype 1 infection in Japan.
J Gastroenterol 2019;
54 (08) 742-751
We do not assume any responsibility for the contents of the web pages of other providers.